title: Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.
abstract: Sequential plasma samples obtained from 16 individuals who seroconverted were tested for the presence of antibody to human immunodeficiency virus type 1 (HIV-1) by an antigen conjugate enzyme immunoassay (EIA) and a conventional antibody conjugate assay. In 11 of these individuals, the antigen conjugate assay detected antibody to HIV-1 2 to 11 days (mean, 5.5 days) earlier than the antibody conjugate assay. In 11 individuals, HIV-1 p24 antigen was detected a median of 6.5 days (range, 3 to 14 days) prior to positivity by the antigen conjugate EIA. Using class-specific probes, we determined the profiles of immunoglobulin M (IgM), IgG, and IgA antibodies for each individual and correlated these profiles with the EIA signals from both assays. In general, the appearance of IgM exhibited a peak at about 1 week postseroconversion, which was followed by gradually declining levels. Absorbance levels for IgG antibody, however, rose steadily and reached a plateau after 3 to 5 weeks. The levels of IgA were generally low and variable. In contrast to the progressive increase in EIA absorbance observed by the antibody conjugate assay, the antigen conjugate assay displayed a rapid early rise in absorbance which generally coincided with the transient expression of IgM antibody. The subsequent gradual increase coincided with rising levels of IgG. Because the configuration of the antigen conjugate EIA allows for an increased sensitivity for IgM compared with that for other classes of immunoglobulins, these results suggest that earlier detection of antibody to HIV-1 is due to the detection of IgM antibody during the early phase of seroconversion.
authors.affiliation: Abbott Laboratories, North Chicago, Illinois 60064.
authors.forename: J L
authors.initials: JL
authors.lastname: Gallarda
authors.forename: D R
authors.initials: DR
authors.lastname: Henrard
authors.forename: D
authors.initials: D
authors.lastname: Liu
authors.forename: S
authors.initials: S
authors.lastname: Harrington
authors.forename: S L
authors.initials: SL
authors.lastname: Stramer
authors.forename: J E
authors.initials: JE
authors.lastname: Valinsky
authors.forename: P
authors.initials: P
authors.lastname: Wu
mesh_terms: D015415:Biomarkers; D015483:HIV Antibodies / Q000032:analysis*; D016655:HIV Core Protein p24 / Q000276:immunology; D006679:HIV Seropositivity / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D015498:HIV-2 / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D007075:Immunoglobulin M / Q000378:metabolism*; D007136:Immunoglobulins / Q000378:metabolism; D012680:Sensitivity and Specificity; D013997:Time Factors
chemical_list: D015415:Biomarkers; D015483:HIV Antibodies; D016655:HIV Core Protein p24; D007075:Immunoglobulin M; D007136:Immunoglobulins